organization · Reporting owner
Valence Investments SPV IV LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CalciMedica, Inc.CALC · Entity 7804 | 10% owner | March 20, 2023 | May 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CalciMedica, Inc.
Report date March 20, 2023 · Filed May 03, 2023
Jointly reported with Valence Investments SPV V, LLC, Valence Investments SPV VI, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 356,989 |
Reported balance
After 2023-03-20 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2023-03-20 · Grant · Acquired 356,989 · Balance 356,989 F1: Received in exchange for an aggregate of 12,395,423 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. |
| Common StockSEC Table I · non-derivative | IndirectBy Valence Investments SPV V, LLC | 66,228 |
Reported balance
After 2023-03-20 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2023-03-20 · Grant · Acquired 66,228 · Balance 66,228 F2: Received in exchange for 2,299,564 shares of the common stock of CalciMedica pursuant to the Merger Agreement. |
| Common StockSEC Table I · non-derivative | IndirectBy Valence Investments SPV VI, LLC | 316,109 |
Reported balance
After 2023-03-20 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2023-03-20 · Grant · Acquired 316,109 · Balance 316,109 F3: Received in exchange for 10,975,977 shares of the common stock of CalciMedica pursuant to the Merger Agreement. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $27.94 · Expires 2026-02-22 | IndirectBy Valence Investments SPV V, LLC | 9,935 |
Reported balance
After 2023-03-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-03-20 · Grant · Acquired 9,935 · Balance 9,935 F5: Received in exchange for a warrant to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement. F4: Immediately exercisable. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $27.94 · Expires 2026-06-25 | IndirectBy Valence Investments SPV V, LLC | 9,935 |
Reported balance
After 2023-03-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-03-20 · Grant · Acquired 9,935 · Balance 9,935 F5: Received in exchange for a warrant to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement. F4: Immediately exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Received in exchange for an aggregate of 12,395,423 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.
F2: Received in exchange for 2,299,564 shares of the common stock of CalciMedica pursuant to the Merger Agreement.
F3: Received in exchange for 10,975,977 shares of the common stock of CalciMedica pursuant to the Merger Agreement.
F4: Immediately exercisable.
F5: Received in exchange for a warrant to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 20, 2023 Filed May 3, 2023 20:53 UTC | CalciMedica, Inc. CALC · Entity 7804 | GrantWarrant · Derivative | 9,935 | Not disclosed Strike: $27.94 | Not disclosed |
DisclosureSEC source: 0001209191-23-027196 · doc4.xml · derivative · entry 5 Valence Investments SPV IV LLC · CIK 0001812080 · 10% owner Valence Investments SPV V, LLC · CIK 0001854361 · 10% owner Valence Investments SPV VI, LLC · CIK 0001971787 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Valence Investments SPV V, LLC Disclosed balance after: 9,935 Underlying: Common Stock · 9,935 shares Expires 2026-06-25 F5 · price: Received in exchange for a warrant to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement. F4 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| March 20, 2023 Filed May 3, 2023 20:53 UTC | CalciMedica, Inc. CALC · Entity 7804 | GrantWarrant · Derivative | 9,935 | Not disclosed Strike: $27.94 | Not disclosed |
DisclosureSEC source: 0001209191-23-027196 · doc4.xml · derivative · entry 4 Valence Investments SPV IV LLC · CIK 0001812080 · 10% owner Valence Investments SPV V, LLC · CIK 0001854361 · 10% owner Valence Investments SPV VI, LLC · CIK 0001971787 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Valence Investments SPV V, LLC Disclosed balance after: 9,935 Underlying: Common Stock · 9,935 shares Expires 2026-02-22 F5 · price: Received in exchange for a warrant to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement. F4 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| March 20, 2023 Filed May 3, 2023 20:53 UTC | CalciMedica, Inc. CALC · Entity 7804 | GrantCommon Stock | 316,109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-027196 · doc4.xml · nonDerivative · entry 3 Valence Investments SPV IV LLC · CIK 0001812080 · 10% owner Valence Investments SPV V, LLC · CIK 0001854361 · 10% owner Valence Investments SPV VI, LLC · CIK 0001971787 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Valence Investments SPV VI, LLC Disclosed balance after: 316,109 F3 · price: Received in exchange for 10,975,977 shares of the common stock of CalciMedica pursuant to the Merger Agreement. Read SEC document |
| March 20, 2023 Filed May 3, 2023 20:53 UTC | CalciMedica, Inc. CALC · Entity 7804 | GrantCommon Stock | 66,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-027196 · doc4.xml · nonDerivative · entry 2 Valence Investments SPV IV LLC · CIK 0001812080 · 10% owner Valence Investments SPV V, LLC · CIK 0001854361 · 10% owner Valence Investments SPV VI, LLC · CIK 0001971787 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Valence Investments SPV V, LLC Disclosed balance after: 66,228 F2 · price: Received in exchange for 2,299,564 shares of the common stock of CalciMedica pursuant to the Merger Agreement. Read SEC document |
| March 20, 2023 Filed May 3, 2023 20:53 UTC | CalciMedica, Inc. CALC · Entity 7804 | GrantCommon Stock | 356,989 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-027196 · doc4.xml · nonDerivative · entry 1 Valence Investments SPV IV LLC · CIK 0001812080 · 10% owner Valence Investments SPV V, LLC · CIK 0001854361 · 10% owner Valence Investments SPV VI, LLC · CIK 0001971787 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,989 F1 · price: Received in exchange for an aggregate of 12,395,423 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.